Saskatchewan to allow pharmacists to draw blood for lab tests, prescribe and moreThe government wants to expand pharmacists’ ability to prescribe drugs, order lab tests and do point-of-care testing. By the numbers: Antidepressants on the riseThe number of prescriptions for antidepressants rose during the COVID-19 pandemic, and patients need to know what’s needed to stop if their symptoms have improved. STIs on the rise: 'Pragmatic approach' recommended for managing chlamydia and gonorrhea Add to your to-do list: Take your patients' sexual history. Some antibiotics associated with acute graft-vs-host disease risk after allogeneic hematopoietic cell transplantation Microbiota injury that may be key. Popular ‘low T’ treatment is safe for men with heart disease, but doctors warn it’s no youth serum More than 5,000 men ages 45-80 at 316 trial sites throughout the U.S. were randomly assigned to get the testosterone gel or the placebo. QUIZ: How much do you know about caring for women with epilepsy? Test your knowledge of managing epilepsy in women throughout their lifespan. A pharmacist’s guide to managing bipolar disorder Bipolar disorder is a chronic condition that requires life-long therapy in most patients in order to prevent relapses. Teenage antidepressant use rises: drug trends report The report notes a “significant increase” in antidepressants by plan members under 19, as well at other notable movements in drugs for ADHD, diabetes and children. Cost for Duchenne muscular dystrophy drug quadruples for Ontario man Arun Crishanth said the cost of Deflazacort, a medication he has taken for over a decade, has increased by more than $1,400 a year. Drug access shortfall Health equity for Canadians is elusive with current prescription patchwork. First Previous 166 167 168 169 170 Next Last
